SCHEMBL19735690

SCHEMBL19735690

CC1(C)OB(c2cccc(C3(c4ccccc4)c4ccccc4C4(c5ccccc5)c5ccccc5-c5cccc3c54)c2)OC1(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 8/20 0.40
LPL P06858 7/20 0.40
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
OPRK1 P41145 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.32
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
P4HB P07237 1/20 0.32
CFTR P13569 1/20 0.31
GOPC Q9HD26 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.31
PDGFRB P09619 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17470489 0.95 LIPG (0.44) LIPGLPLESR1ESR2LMNA
SCHEMBL29603064 0.95 LIPG (0.44) LIPGLPLESR1ESR2LMNA
SCHEMBL17816784 0.93 LIPG (0.43) LIPGLPLESR1ESR2LMNA
SCHEMBL12166505 0.92 LIPG (0.43) LIPGLPLESR1ESR2LMNA
SCHEMBL19735704 0.90 LIPG (0.49) LIPGLPLESR1ESR2LMNA
SCHEMBL19760001 0.89 LIPG (0.42) LIPGLPLESR1ESR2LMNA
SCHEMBL22173457 0.89 LIPG (0.52) LIPGLPLESR1ESR2LMNA
SCHEMBL19759992 0.89 LIPG (0.42) LIPGLPLESR1ESR2LMNA
SCHEMBL22173458 0.87 LIPG (0.50) LIPGLPLESR1ESR2LMNA
SCHEMBL105120 0.85 LPL (0.38) LIPGLPLESR1ESR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3369719-B1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEMICAL LTD (KR) 2020-02-26 EP disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 LIPG 3747/4885LPL 2394/4885ESR1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.